Stopping and re-starting amiodarone for atrial fibrillation is more dangerous than continuous use

A study in the October 15 issue of JAMA indicates that reducing how often a patient receives amiodarone for atrial fibrillation does not decrease side effects, but does increase atrial fibrillation recurrence and the risk of death and hospitalizations.

Read: Continuous use of amiodarone for atrial fibrillation better than episodic use